The anti-inflammatory peptide Catestatin blocks chemotaxis

J Leukoc Biol. 2022 Aug;112(2):273-278. doi: 10.1002/JLB.3CRA1220-790RR. Epub 2021 Dec 22.

Abstract

Increased levels of the anti-inflammatory peptide Catestatin (CST), a cleavage product of the pro-hormone chromogranin A, correlate with less severe outcomes in hypertension, colitis, and diabetes. However, it is unknown how CST reduces the infiltration of monocytes and macrophages (Mϕs) in inflamed tissues. Here, it is reported that CST blocks leukocyte migration toward inflammatory chemokines. By in vitro and in vivo migration assays, it is shown that although CST itself is chemotactic, it blocks migration of monocytes and neutrophils to inflammatory attracting factor CC-chemokine ligand 2 (CCL2) and C-X-C motif chemokine ligand 2 (CXCL2). Moreover, it directs CX3 CR1+ Mϕs away from pancreatic islets. These findings suggest that the anti-inflammatory actions of CST are partly caused by its regulation of chemotaxis.

Keywords: Mϕs; catestatin; chemotaxis; migration; monocytes; neutrophil; pro-angiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Chemokine CCL2 / pharmacology
  • Chemokines / pharmacology
  • Chemotaxis*
  • Chemotaxis, Leukocyte*
  • Chromogranin A / pharmacology
  • Ligands
  • Neutrophils
  • Peptide Fragments
  • Peptides / pharmacology

Substances

  • Anti-Inflammatory Agents
  • Chemokine CCL2
  • Chemokines
  • Chromogranin A
  • Ligands
  • Peptide Fragments
  • Peptides
  • chromogranin A (344-364)